PND 1186: Clinical Trials

2 trials of PND 1186, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 1, Withdrawn 1

Follow PND 1186: new trials by email Literature Review of PND 1186 trials Research Report on PND 1186

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies
VS-4718 - Non Hematologic Cancers, Metastatic Cancer
Phase 1TerminatedVerastem, Inc.482013-06-012017-07-28
Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia
VS-4718 - Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Phase 1WithdrawnVerastem, Inc.2017-01-27

Conditions studied

Burkitt Lymphoma (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)

Sponsors

Verastem, Inc. (2)

Countries

United States (1)

Top investigators

Hagop Youssoufian, MD (2)